tariquidar has been researched along with buthionine sulfoximine in 2 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (buthionine sulfoximine) | Trials (buthionine sulfoximine) | Recent Studies (post-2010) (buthionine sulfoximine) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 2,460 | 8 | 408 |
| 210 | 16 | 138 | 20 | 0 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, SX; Gong, MQ; He, XY; Wu, C; Wu, JL; Zhuo, RX; Zong, JY | 1 |
| Brimacombe, KR; Dulcey, AE; Goldsborough, AS; Gottesman, MM; Griffiths, G; Hall, MD; Handley, MD; Kannan, P; Pluchino, KM | 1 |
2 other study(ies) available for tariquidar and buthionine sulfoximine
| Article | Year |
|---|---|
Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotin; Buthionine Sulfoximine; Calcium Carbonate; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Glutathione; HeLa Cells; Heparin; Humans; MCF-7 Cells; Nanoparticles; Polymers; Protamines; Quinolines | 2017 |
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Orphan Drug Production; Paclitaxel; RNA Stability; RNA, Messenger; Structure-Activity Relationship; Tiopronin | 2011 |